Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CHRS compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
CHRS
Coherus Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
CHRS
Coherus Oncology, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
CHRS
Coherus Oncology, Inc.
Change
0.86
· pre 0.85
· delayed
Mkt cap
$131.4M
Revenue
$14M
Q2 FY26
Revenue
$42M
FY25
AMGN
Amgen Inc
Change
478.34
· pre 482.52
· delayed
Pre-market
Nov 5 '26
delayed
Mkt cap
$258.8B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
vs
Compare
Pre-market
Nov 5 '26
delayed
CHRS
Coherus Oncology, Inc.
vs
AMGN
Amgen Inc
0.86
pre 0.85
delayed
Price
478.34
pre 482.52
delayed
$131.4M
Mkt cap
$258.8B
Q2 FY26
$14M
Revenue
$10.4B
Q3 FY26
FY25
$42M
Revenue
$36.8B
FY25
Change
Change
CHRS
0.86
vs
AMGN
478.34
Pre-market
Nov 5 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CHRS, solid
AMGN, dashed
Supply-chain overlap
Revenue flow
CHRS: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CHRS
7
GSK
GlaxoSmithKline
supplier
INO
Inovio Pharmaceuticals
customer
—
Junshi Biosciences
unlisted
supplier
—
Janssen Research & Development
unlisted
supplier
3 more · CHRS chain
›
Shared
0
No shared counterparties.
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
8 more · AMGN chain
›